If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
105.50    -2.50 (-2.31%)
Bid:
103.00
Ask:
108.00
Spread: 5.00 (4.854%)
Market Cap: £63.47m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

New Partnership

14 Nov 2011 07:00

RNS Number : 9875R
Intercede Group PLC
14 November 2011
 



14 November 2011

 

Intercede Group plc ("Intercede")

NEW PARTNERSHIP

Intercede announces MyID now part of HP Assured Identity Plus

Large Scale Identity Programs Targeted

 

Intercede (London Stock Exchange AIM: IGP), the producer of MyID, a world-leader in identity and credential management systems (IDCMS), announces that HP now offers MyID as a component of its Assured Identity Plus solutions. Under the agreement, Intercede and HP will target large scale Federal, state and local government agencies and major enterprise customers.

Intercede's MyID Identity and Credential Management System is a secure and powerful COTS product that sets a new standard for ease of use and integration. MyID is used by 14 US Federal Agencies and is deployed in support of more than 2 million smart cards issued under the Transportation Worker Identity Credential (TWIC) program. Corporate customers include major banks, aerospace and defense contractors and other organizations with high value assets. Around the world, MyID is used for national ID programs and major health care initiatives.

Today, securely managing the identities of employees is a priority for government agencies and major corporations. The Global Identity Practice within the Enterprise Services organization at HP is a proven leader in developing and implementing enterprise-wide and end-to-end identity management solutions. HP Assured Identity Plus offers a more cost effective solution driven by organizational processes based on best-of-breed COTS products like Intercede MyID.

Richard Parris, Chief Executive at Intercede, commented: "I am delighted that Intercede is collaborating with HP to deliver identity management solutions and that MyID is now part of HP's Assured Identity Plus offering. Intercede MyID delivers secure user, card and credential management that is easily configured to meet the specific security needs for logical and physical access. Its recognition by HP is another very significant industry endorsement, and will deliver a wealth of new business opportunities."

"Our clients are looking for proven identity and credential management solutions that satisfy their security requirements," said Todd Musselman, Global Identity Practice Lead, U.S. Public Sector, Enterprise Services, HP. "Working with Intercede, our Assured Identity Plus solution will streamline the time required to establish and manage identity while providing self-service functions to employees improving availability."

 

 

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Tel. +44 (0)20 7600 1658

Charles Cunningham

Rose Herbert

Joanna Weaving

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

Clare Gilbey

 

 

 

About Intercede

Intercede is the producer of the MyID Identity and Credential Management System (IDCMS).

Intercede MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 federal agencies, two million smart cards in support of the US Transportation Worker Identity Credential program (TWIC), four US financial institutions and 320,000 smart corporate identity badges for Boeing, Booz Allen Hamilton and Lockheed Martin. In Europe, Australasia and the Middle East, Intercede MyID is being deployed in support of government identity, financial services, health and corporate employee ID security projects.

Intercede MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

Intercede MyID was the first electronic personalization product to achieve compliance with the US FIPS-201 Personal Identity Verification (PIV) standard and is widely deployed by federal agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible deployments.

It can issue and manage a wide variety of IDs and credentials, providing customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

For more information visit www.intercede.com

 

HP Assured Identity Plus Overview:

http://h20195.www2.hp.com/V2/GetPDF.aspx/4AA2-8833ENW.pdf

 

Older format:

http://www.hpcollateral.com/Files/EcoCollateral_20100429_4AA2-8833ENW_ohua.pdf

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SALLLFSRLELLLIL
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.